Business Context and Reporting Period
This Form 6-K filing by UBS Group AG and UBS AG, dated January 21, 2020, reports a strategic transaction rather than periodic financial results. The filing announces an agreement to sell a majority stake in UBS Fondcenter, the bank's B2B fund distribution platform, to Clearstream, a subsidiary of Deutsche Börse Group.
Key Financial Metrics and Transaction Details
The filing does not provide standard periodic financial metrics such as revenue, profit, cash flow, or debt levels for a specific reporting period. Instead, it outlines the projected financial impact of the proposed transaction:
- Transaction Scope: Sale of a 51.2% majority stake in UBS Fondcenter.
- Combined Entity Scale: The new entity will hold approximately USD 230 billion in Assets under Administration (AuA).
- Projected Gain: UBS expects to recognize a post-tax gain of approximately USD 600 million upon closing.
- Capital Impact: The transaction is expected to result in a Common Equity Tier 1 (CET1) capital increase of approximately USD 400 million.
- Future Ownership: UBS will retain a 48.8% minority shareholding and account for it as an investment in an associate.
Material Changes and Strategic Shifts
There are no comparative financial changes versus a prior period as this is a one-time event filing. The material change is the divestiture of a majority interest in the Fondcenter business unit. This move is designed to:
- Deconsolidate Fondcenter from UBS's balance sheet.
- Allow UBS Asset Management to focus on strategic priorities for profitable growth.
- Create a top-two global B2B fund distribution platform through the combination with Clearstream's Fund Desk.
Outlook, Risks, and Management Commentary
Management Commentary: CEO Sergio P. Ermotti stated the deal builds on a successful long-term relationship and will create significant value for shareholders through greater scale. UBS AM President Suni Harford noted the move enables a sharper focus on strategic execution.
Timeline and Conditions: The transaction is subject to customary closing conditions and is expected to close in the second half of 2020.
Risks and Contingencies: The filing includes a standard cautionary statement regarding forward-looking statements. Actual results may differ materially due to risks, uncertainties, and other factors. The deal is contingent on regulatory approvals and customary closing conditions.
Key Facts for Investor Verification
- Verify the final closing date, as the transaction is currently expected in the second half of 2020 but is subject to conditions.
- Confirm the actual post-tax gain and CET1 capital increase upon closing, as current figures are estimates.
- Review the terms of the long-term commercial cooperation arrangements between UBS and the new Fondcenter entity.
- Monitor the status of the option for UBS to sell its remaining 48.8% minority stake to Clearstream at a later date.